Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
23,748 total articles
Option Care Health, the largest independent provider of home and alternate site infusion services in the U.S., announced that its CEO and CFO will present at the Morgan Stanley Global Healthcare Conference and Deutsche Bank Healthcare Summit in September 2026. The company aims to share its business outlook and strategies with investors during these…
Surrozen, Inc., a Nasdaq-listed biotechnology company focused on Wnt signaling therapeutics for sight-threatening ophthalmic diseases, announced that its management will present at the 2026 Cantor Global Healthcare and Morgan Stanley Global Healthcare conferences. The company provided updates on its development plans including initiating a Phase 1b…
Superior Group of Companies, Inc. announced that its CEO Michael Benstock and President/CFO Mike Koempel will participate in the Northcoast Research and Sidoti virtual conferences in September 2026, including investor meetings and a fireside chat. The company highlighted its diversified business segments and strategy focused on organic growth and a…
Robinhood Markets, Inc. announced that CEO Vlad Tenev will present at the upcoming Goldman Sachs Communacopia + Technology Conference. The presentation will be webcast live and available for replay, providing investors insights into company developments and strategy.
Attovia Therapeutics announced second quarter 2026 financial results alongside positive clinical updates for its lead product ATTO-1310 in treating chronic pruritus and atopic dermatitis. The company plans Phase 2 studies for 2027 and has strengthened its cash runway into 2030 following an upsized IPO raising $332.4 million. Additional pipeline can…
SOLOWIN HOLDINGS (Nasdaq: AXG) announced that its subsidiary AlloyX HK has signed a strategic non-binding MOU with EvolveQ to explore the integration of AI, quantum computing, and high-performance computing in finance and digital assets. The collaboration aims to develop next-generation AI wealth management platforms, enhance AI infrastructure, and…
Shattuck Labs, a clinical-stage biotech company focused on developing monoclonal and bispecific DR3 blocking antibodies for inflammatory and immune diseases, announced that management will participate in the Wells Fargo 21st Annual Healthcare Conference and the Cantor Global Healthcare Conference in September 2026. The presentations will include fi…
PowerCompute, a Nasdaq-listed Bitcoin treasury and mining company expanding into high-performance computing (HPC) and artificial intelligence (AI) infrastructure, will participate in the H.C. Wainwright 28th Annual Global Investment Conference. The company highlighted its Verified status on the Vast.ai compute marketplace and recent acquisition of …
Elutia Inc., a Nasdaq-listed company specializing in drug-eluting biomatrix technologies, announced its participation in the Lake Street Capital Markets 10th Annual Big Ideas Growth Conference and the H.C. Wainwright 28th Annual Global Investment Conference. The company’s leadership will present their technology developments focused on addressing p…
Netskope, Inc. announced its Q2 fiscal 2027 financial results showing a 27% year-over-year increase in annual recurring revenue to $899 million and 29% revenue growth to $221 million. The company exceeded guidance across all key metrics driven by innovation and strong customer demand for its Netskope One platform, including early traction in AI sec…
Appian announced that its CFO, Serge Tanjga, will present at Citi's Global TMT Conference in New York, delivering a live webcasted fireside chat focusing on the company's AI automation platform for enterprise business processes. The presentation highlights Appian's ongoing commitment to AI-powered process automation for large organizations.
SPS Commerce, a leading intelligent supply chain network company, announced its management will present at Citi's 2026 Global TMT Conference. The presentation underscores SPS Commerce's role in connecting trading partners globally through AI-powered solutions to optimize supply chain operations.
Amwell (NYSE: AMWL), a leader in technology-enabled healthcare platforms, announced that its CFO and COO Mark Hirschhorn will represent the company at two prestigious investor conferences in September 2026. These events include the Wells Fargo 21st Annual Healthcare Conference and the Morgan Stanley 24th Annual Global Healthcare Conference, where t…
Scribe Therapeutics reported second-quarter 2026 financial results alongside key corporate milestones including the initiation of the first-in-human Phase 1 trial for STX-1150, a novel CRISPR-based LDL-C lowering therapy. The company secured over $25 million from the California Institute for Regenerative Medicine to advance cardiometabolic gene-edi…
Gold.com, a leading integrated alternative assets platform specializing in precious metals and collectibles, reported robust fiscal fourth quarter and full year 2026 financial results. The company achieved significant revenue growth driven by organic expansion, strategic acquisitions including Sunshine Minting, and increased sales volume. Net incom…
Nyxoah announced that its ACCCESS U.S. pivotal study for the Genio system successfully met primary safety and efficacy endpoints in patients with Complete Concentric Collapse (CCC) obstructive sleep apnea (OSA). The study reported a 77.2% Apnea-Hypopnea Index (AHI) responder rate and zero device-related serious adverse events over 12 months. The re…
Matrix Service Company announced Q4 fiscal 2026 revenue growth to $244.5 million, the highest quarterly revenue in six years, with a net income of $1.1 million compared to a loss in the prior year. The company achieved adjusted net income for the second consecutive profitable quarter and ended the fiscal year with liquidity of $283.9 million and no…
Kymera Therapeutics, a clinical-stage biopharmaceutical company specializing in targeted protein degradation for immunological diseases, announced its participation in several upcoming investor conferences throughout September 2026. The company will present and participate in fireside chats at major events hosted by Wells Fargo, Citi, H.C. Wainwrig…
Aura Biosciences, a clinical-stage biotechnology company focused on developing a novel therapy for ocular cancers, announced its CEO, Natalie Holles, will participate in the Morgan Stanley 24th Annual Global Healthcare Conference. The company highlighted its Phase 3 fully enrolled trial for bel-sar in early choroidal melanoma and ongoing studies in…
Black Diamond Therapeutics announced its participation in the H.C. Wainwright 28th Annual Global Investment Conference, with a presentation and one-on-one investor meetings scheduled. The company highlighted advancements in its investigational EGFR inhibitor, silevertinib, targeting oncology indications such as EGFR-mutant non-small cell lung cance…
Duolingo announced that CEO Luis von Ahn will participate in a fireside chat at the Citi 2026 Global TMT Conference. The event will be webcast live and later available for replay. Duolingo is recognized as the leading mobile language learning platform globally, known for its highly popular app and commitment to quality and accessibility in educatio…
Spero Therapeutics, a clinical-stage biopharmaceutical company specializing in immunology and inflammation, announced that its CEO, Esther Rajavelu, will present at the upcoming H.C. Wainwright 28th Annual Global Investment Conference. The presentation will cover the company’s pipeline with a focus on its lead program, SP001, targeting immune-media…
Oxford Lane Capital Corp., a closed-end management investment company focusing on CLO debt and equity tranches, announced it will redeem $30 million aggregate principal amount of its 5.00% Notes due 2027 at $25 per Note plus accrued interest, with redemption effective October 2, 2026. The Notes trade on Nasdaq under ticker OXLCZ.
Ultragenyx Pharmaceutical announced that its Phase 3 Aspire clinical trial of apazunersen (GTX-102) for Angelman syndrome did not meet the primary or key secondary efficacy endpoints. Despite a consistent safety profile, the company expressed disappointment and will evaluate the future of the program while planning to implement significant expense …
Five Below, Inc. delivered solid financial results for Q2 FY 2026, with net sales increasing 22.9% to $1.26 billion and comparable sales up 14.1%. Operating income surged significantly, and diluted EPS increased to $3.99 from $0.77 year-over-year. The company opened 52 net new stores this quarter, totaling 2,022 stores nationwide. With strong momen…
